🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT05821972
Recruiting Phase 4

Nebulized Dexmedetomidine Combined With Ketamine Versus Nebulized Dexmedetomidine for Cleft Palate

NCT05821972 · tracked via the Priya Life Science Egypt tracker
Phase
Phase 4
Started
2024-04-10
Last updated
2025-10-03

Condition(s) studied

SedationEmergence Delirium

Investigational drug(s) / intervention(s)

Nebulization of dexmedetomidine and ketamineNebulization of dexmedetomidine

Nebulization of dexmedetomidine and ketamine: Pre-operative nebulization of dexmedetomidine and ketamine

Nebulization of dexmedetomidine: Pre-operative nebulization of dexmedetomidine

Study summary

To compare the efficacy of the pre-operative nebulization of a combination of dexmedetomidine and ketamine versus nebulization of dexmedetomidine alone for sedation and prevention of emergence delirium in children undergoing cleft palate repair surgeries.

Eligibility

Sex
ALL
Min age
12 Months
Max age
48 Months
Healthy volunteers
No
Inclusion Criteria: * Patients with American Society of Anesthesiologists (ASA) physical status I \& II who will be scheduled for cleft palate repair surgeries Exclusion Criteria: * Parent refusal * Allergy to the study drugs * Suspected difficult airway * Patients with endocrine, renal, hepatic, and cardiac pathology * Psychiatric diseases * Asthmatic patients.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Assiut University Asyut Egypt Recruiting

More Assiut University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05821972 on ClinicalTrials.gov ↗ ← All trials in Egypt